Saturday, November 26, 2022

Tag: physician-initiated study of NP-120 (Ifenprodil) for COVID-19 infected patients


How to reduce the impact of COVID-19

The Coronavirus, or COVID-19 to use its correct name, has caused unprecedented disruptions for global supply chains. Not only do we see huge delays...
Algernon Pharma

Algernon Pharma appoints Novotech to begin phase 2 trial of Ifenprodil...

Algernon Pharma, a clinical-stage pharmaceutical development company, has announced that it has chosen to appoint award-winning Novotech as the contract research organization (“CRO”) for...

This function has been disabled for HealthTekPak.

error: Content is protected !!